-

We’re Not Giving Away Your Shot – Wolters Kluwer Pharmacist Explains COVID-19 Vaccine Shot vs. Booster Confusion

Kristen Nichols, PharmD of Wolters Kluwer, explains that a vaccine booster is not the same as a second or third dose of the COVID-19 vaccines

WALTHAM, Mass.--(BUSINESS WIRE)--What: The most recent recommendations from the CDC advise that immunocompromised patients receive an additional dose of the COVID-19 MRNA vaccines made by Moderna and Pfizer. The White House also announced they were recommending people start to receive a booster shot of the MRNA vaccines eight months after their second dose.

Why: Early data are showing that the two-dose COVID-19 vaccine regimen for immunocompromised patients may not be enough to in some immunocompromised individuals help their immune system fight off the COVID-19 virus. The CDC recommended the third shot to help those whose immune systems may not have responded.

Who: Kristen Nichols, PharmD, BCPS, BCPPS, BCIDP, Senior Content Management Consultant, Pediatric Infectious Diseases, Wolters Kluwer, is a pharmacist who has been on the front lines of administering COVID-19 vaccines and is also an adjunct professor at Butler University. One detail she believes is missing from the conversation around the CDC and White House recommendations is the difference between a booster and a vaccine.

“The Advisory Committee on Immunization Practices (ACIP) has been particular about the terminology. What was authorized for immunocompromised patients is an additional dose, not a booster. An additional dose is for people who may not have responded adequately to the initial two-dose regimen, specifically those who are moderate to severely immunocompromised. A third dose doesn’t necessarily guarantee that they’ll respond, but several patients who received a solid organ transplant and didn’t respond to the initial 2 doses did respond to a third.”

“Boosters are doses that are given to people who likely had an adequate initial response but whose immunity may have waned over time. This would be your typical healthy person who got vaccinated originally but now needs to ‘re-invigorate’ that protection.”

How: Contact Ashley Beine at ashley.beine@wolterskluwer.com to schedule an interview with Kristen Nichols. Journalists may also publish the quote above with proper attribution.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

Contacts

Media
Ashley Beine
Sr. Public Relations and Public Affairs Specialist
Wolters Kluwer Health
+1 (262) 685-8721
ashley.beine@wolterskluwer.com

Wolters Kluwer Health

AEX:WKL

Release Versions

Contacts

Media
Ashley Beine
Sr. Public Relations and Public Affairs Specialist
Wolters Kluwer Health
+1 (262) 685-8721
ashley.beine@wolterskluwer.com

More News From Wolters Kluwer Health

Wolters Kluwer report: unified and proactive care that addresses social drivers of health can help reduce cardiovascular disease

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health released a new report outlining how healthcare leaders can help drive better patient outcomes for cardiovascular health....

Wolters Kluwer Survey: Over Two-Thirds of U.S. Physicians Have Changed Their Mind, Now Viewing GenAI as Beneficial in Healthcare

WALTHAM, Mass.--(BUSINESS WIRE)--A Wolters Kluwer Health survey finds 68% of U.S. physicians changed views in the last year, now more likely view GenAI as beneficial to healthcare....

Wolters Kluwer supports Brazil with access to trusted medical content on Dengue disease

SÃO PAULO--(BUSINESS WIRE)--With the significant growth of Dengue cases in Brazil, Wolters Kluwer Health is providing free, online access to evidence-based information about the disease from its clinical decision support (CDS) resource, UpToDate. Access is available to doctors, even if they are not UpToDate subscribers, as well as to the general community by visiting this link. According to data from the Brazilian Ministry of Health, by the second week of March 2024, more than 1.3 million proba...
Back to Newsroom